To conduct a scoping review on etiologic investigation of prelingual hearing loss among children <2 years of age in the era of universal newborn hearing screening (UNHS).
Data Sources
PubMed, Embase, PsycInfo, CINAHL, and Cochrane Library databases.
Review Methods
We searched for articles published from January 1, 1998, to February 19, 2020. We reviewed studies that (1) included children identified with either congenital or delayed-onset hearing loss before 2 years of age among cohorts who had undergone UNHS and (2) investigated ≥1 etiologies of hearing loss. We defined hearing loss as congenital when confirmed after UNHS failure and as delayed onset when diagnosed after ≥1 assessments with normal hearing.
Results
Among 2069 unique citations, 115 studies met criteria for full-text assessment, and 20 met our inclusion criteria. Six studies tested children diagnosed with hearing loss for genetic etiology, 9 for congenital cytomegalovirus (CMV) infection, and 5 for both. Among 1787 children with congenital hearing loss and etiologic investigation, 933 (52.2%) were tested for genetic mutations and 1021 (57.1%) for congenital CMV infection. The proportion of congenital hearing loss cases attributable to genetic etiology ranged between 7.7% and 83.3% and to congenital CMV infection between 0.0% and 32.0%.
Conclusion
Data are lacking on the identification and etiology of delayed-onset hearing loss in children <2 years of age in the UNHS era. The proportion of congenital hearing loss cases attributable to genetic etiologies and congenital CMV infection appears to vary widely.
National Research Council. Hearing Loss: Determining Eligibility for Social Security Benefits. Washington, DC: National Academies Press; 2004.
2.
StikaCJEisenbergLSJohnsonKC, et al. Developmental outcomes of early-identified children who are hard of hearing at 12 to 18 months of age. Early Hum Dev. 2015;91:47-55.
3.
VohrBJodoin-krauzykJTuckerR, et al. Early language outcomes of early-identified infants with permanent hearing loss at 12 to 16 months of age. Pediatrics. 2008;122:535-544.
4.
Yoshinaga-ItanoC. From screening to early identification and intervention: discovering predictors to successful outcomes for children with significant hearing loss. J Deaf Stud Deaf Educ. 2003;8:11-30.
5.
American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007;120:898-921.
MunnZPetersMDJSternC, et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18:143.
8.
TriccoACLillieEZarinW, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169:467-473.
9.
DeanAGSullivanKMSoeMM. OpenEpi: open source epidemiologic statistics for public health. Version 3. http://www.OpenEpi.com. Accessed February 7, 2020.
10.
RawlinsonWDPalasanthiranPHallB, et al. Neonates with congenital cytomegalovirus and hearing loss identified via the universal newborn hearing screening program. J Clin Virol. 2018;102:110-115.
11.
BeswickRDavidMHigashiH, et al. Integration of congenital cytomegalovirus screening within a newborn hearing screening programme. J Paed Child Health. 2019;55:1381-1388.
12.
DeclauFBoudewynsAVan den EndeJ, et al. Etiologic and audiologic evaluations after universal neonatal hearing screening: analysis of 170 referred neonates. Pediatrics. 2008;121:1119-1126.
13.
BoudewynsADeclauFSmetsK, et al. Cytomegalovirus DNA detection in Guthrie cards: role in the diagnostic work-up of childhood hearing loss. Otol Neurotol. 2009;30:943-949.
14.
YamamotoAYAnastasioARTMassudaET, et al. Contribution of congenital cytomegalovirus (cCMV) to permanent hearing loss in a highly seropositive population: the BraCHS study. Clin Infect Dis. 2019;17:17.
15.
GuoLXiangJSunL, et al. Concurrent hearing and genetic screening in a general newborn population. Hum Genet. 2020;30:30.
16.
ZaputovicSStimacTPrpicI, et al. Molecular analysis in diagnostic procedure of hearing impairment in newborns. Croatian Med J. 2005;46:797-800.
17.
DarLNamdeoDKumarP, et al. Congenital cytomegalovirus infection and permanent hearing loss in rural north Indian children. Pediatr Infect Dis J. 2017;36:670-673.
18.
SmithAO’ConnorAHennessyS, et al. Permanent childhood hearing impairment: aetiological evaluation of infants identified through the Irish newborn hearing screening programme. J Irish Med Org. 2017;110:651-651.
19.
Ari-Even RothDLubinDKuintJ, et al. Contribution of targeted saliva screening for congenital CMV-related hearing loss in newborns who fail hearing screening. Arch Dis Child Fetal Neonatal Ed. 2017;102:F519-F524.
20.
ChinettiVIossaSAulettaG, et al. Mutational analysis for GJB2, GJB6, and GJB3 genes in Campania within a universal neonatal hearing screening programme. Int J Audiol. 2011;50:866-870.
21.
YamaguchiAOh-IshiTAraiT, et al. Screening for seemingly healthy newborns with congenital cytomegalovirus infection by quantitative real-time polymerase chain reaction using newborn urine: an observational study. BMJ Open. 2017;7:e013810.
22.
NelsonSAndersenRAnderssenSH. Hearing loss in children in Ostfold county 2000-09. Tidsskr Nor Laegeforen. 2015;135:132-136.
23.
ChuCWChenYJLeeYH, et al. Government-funded universal newborn hearing screening and genetic analyses of deafness predisposing genes in Taiwan. Int J Pediatr Otorhinolaryngol. 2015;79:584-590.
24.
LuCYTsaoPNKeYY, et al. Concurrent hearing, genetic, and cytomegalovirus screening in newborns, Taiwan. J Pediatr. 2018;199:144-150, e1.
25.
WilliamsEJKadambariSBerringtonJE, et al. Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss. Arch Dis Child Fetal Neonatal Ed. 2014;99:F230-F236.
26.
StehelEKShoupAGOwenKE, et al. Newborn hearing screening and detection of congenital cytomegalovirus infection. Pediatrics. 2008;121:970-975.
27.
DentKMKennesonAPalumbosJC, et al. Methodology of a multistate study of congenital hearing loss: preliminary data from Utah newborn screening. Am J Med Genet C Semin Med Genet. 2004;125C:28-34.
28.
DienerMLZickCDMcVicarSB, et al. Outcomes from a hearing-targeted cytomegalovirus screening program. Pediatrics. 2017;139:e20160789.
29.
VancorEShapiroEDLoyalJ. Results of a targeted screening program for congenital cytomegalovirus infection in infants who fail newborn hearing screening. J Pediatric Infect Dis Soc. 2019;8:55-59.
30.
British Association of Audiovestibular Physicians. Guidelines for Investigating Infants with Congenital Hearing Loss Identified through the Newborn Hearing Screening: Best Practice Guidelines. British Association of Audiovestibular Physicians; 2008.
31.
GrosseSDRossDSDollardSC. Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment. J Clin Virol. 2008;41:57-62.
32.
FowlerKBRossSAShimamuraM, et al. Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection. J Pediatr. 2018;200:196-201, e1.
33.
FowlerKBDahleAJBoppanaSB, et al. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?J Pediatr. 1999;135:60-64.
34.
FowlerKBMcCollisterFPDahleAJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr. 1997;130:624-630.
35.
FowlerKBMcCollisterFPSaboDL, et al. A targeted approach for congenital cytomegalovirus screening within newborn hearing screening. Pediatrics. 2017;139(2).
36.
LanzieriTMChungWFloresM, et al. Hearing loss in children with asymptomatic congenital cytomegalovirus infection. Pediatrics. 2017;139(3).
37.
Avettand-FenoelVMarlinSVauloup-FellousC, et al. Congenital cytomegalovirus is the second most frequent cause of bilateral hearing loss in young French children. J Pediatr. 2013;162:593-599.
38.
LimingBJCarterJChengA, et al. International Pediatric Otolaryngology Group (IPOG) consensus recommendations: hearing loss in the pediatric patient. Int J Pediatr Otorhinolaryngol. 2016;90:251-258.
39.
KawadaJToriiYKawanoY, et al. Viral load in children with congenital cytomegalovirus infection identified on newborn hearing screening. J Clin Virol. 2015;65:41-45.
40.
KadambariSLuckSDavisA, et al. Evaluating the feasibility of integrating salivary testing for congenital CMV into the Newborn Hearing Screening Programme in the UK. Eur J Pediatr. 2015;174:1117-1121.
41.
ChoiKYSchimmentiLAJurekAM, et al. Detection of cytomegalovirus DNA in dried blood spots of Minnesota infants who do not pass newborn hearing screening. Pediatr Infect Dis J. 2009;28:1095-1098.
42.
GernerdeGarciaBGaffneyCChaconS, et al. Overview of newborn hearing screening activities in Latin America. Rev Panam Salud Publica. 2011;29:145-152.
43.
DaiPHuangLHWangGJ, et al. Concurrent hearing and genetic screening of 180,469 neonates with follow-up in Beijing, China. Am J Hum Genet. 2019;105:803-812.
44.
HaoZFuDMingY, et al. Large scale newborn deafness genetic screening of 142,417 neonates in Wuhan, China. PLoS One. 2018;13:e0195740.
45.
LiuYYeLZhuP, et al. Genetic screening involving 101 hot spots for neonates not passing newborn hearing screening and those random recruited in Dongguan. Int J Pediatr Otorhinolaryngol. 2019;117:82-87.
46.
WangQHanBZhangZ, et al. Newborn gene screening for high risk deafness-associated mutations with a new tetra-primer AR MS PCR kit. Clin Chem. 2012;1:A37.
47.
WuCCTsaiCHHungCC, et al. Newborn genetic screening for hearing impairment: a population-based longitudinal study. Genet Med. 2017;19:6-12.
48.
JaneckeARDahlH-HMChingTYC, et al. Etiology and audiological outcomes at 3 years for 364 children in Australia. PLoS One. 2013;8:e59624.
49.
DedhiaKKitskoDSaboD, et al. Children with sensorineural hearing loss after passing the newborn hearing screen. JAMA Otolaryngol Head Neck Surg. 2013;139:119-123.
50.
ParkAH. Randomized controlled trial of valganciclovir for asymptomatic cytomegalovirus incected hearing impaired infants (ValEAR). https://clinicaltrials.gov/ct2/show/NCT03107871. First posted April11, 2017. Last update posted July29, 2019.
51.
GoodwinSMcPhersonJMcCombieW. Coming of age: ten years of next-generation sequencing technologies. Nature Rev Genet. 2016;17:331-351.
52.
ShearerAESmithRJ. Massively parallel sequencing for genetic diagnosis of hearing loss: the new standard of care. Otolaryngol Head Neck Surg. 2015;153:175-182.
53.
DunnJBagattoMBartonM, et al. Targeted identification and treatment of infants with cCMV via dried bloodspot PCR as an expanded hearing screen. Presented at: Seventh International Congenital CMV Conference and 17th International CMV Workshop; April7-11, 2019; Birmingham, Alabama.
54.
ShearerAEShenJAmrS, et al. A proposal for comprehensive newborn hearing screening to improve identification of deaf and hard-of-hearing children. Genet Med. 2019;21(11):2614-2630.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
